Page last updated: 2024-08-23

teprotide and Hematologic Malignancies

teprotide has been researched along with Hematologic Malignancies in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ballestrero, A; Bello, C; Cea, M; Cirmena, G; Dal Bello, G; Duchosal, MA; Dupuis, M; Fruscione, F; Garuti, A; Grossi, F; Moran, E; Nahimana, A; Nencioni, A; Patrone, F; Pronzato, P; Rocco, I; Sordat, B; Vogel, P	1

Other Studies

1 other study(ies) available for teprotide and Hematologic Malignancies

Article	Year
Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies. Bioorganic & medicinal chemistry, 2010, May-01, Volume: 18, Issue:9 Topics: alpha-Mannosidase; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Hematologic Neoplasms; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Teprotide	2010

Article

Year

Novel 2-[(benzylamino)methyl]pyrrolidine-3,4-diol derivatives as alpha-mannosidase inhibitors and with antitumor activities against hematological and solid malignancies.

Bioorganic & medicinal chemistry, 2010, May-01, Volume: 18, Issue:9

Topics: alpha-Mannosidase; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Hematologic Neoplasms; Humans; Inhibitory Concentration 50; Molecular Structure; Neoplasms; Teprotide

2010